Shimadzu has announced that it will participate in the Yuichi Sugiyama Special Laboratory at RIKEN, supported by 26 Japanese companies, on micro-dose PET studies based on stable isotopes for clinical studies on humans unsing Shimadzu’s highly sensitive MS-MS system

Shimadzu press release, April 11, 2012